Literature DB >> 12076688

Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection.

Dario Cattaneo1, Norberto Perico, Flavio Gaspari.   

Abstract

A novel, reversed-phase high-performance liquid chromatographic (HPLC) method is described for the analysis of sirolimus (SRL) in whole blood. The samples were purified by precipitating blood matrix with zinc sulfate, SRL was then extracted with acetone followed by solid-phase extraction. The method was linear over a range of 1-100 ng/ml and the lower limit of quantification was 2.5 ng/ml. The coefficient of variation (within day) was below 8.0% for the lowest SRL concentration. The day-to-day coefficient of variation was below 6.6%. The assay did not show interference peaks with immunosuppressive drugs commonly given to transplant patients. With the simplified extraction procedure described, 60 samples (including controls and calibration curve) can be quantified in a day. The sensitivity and rapidity of this analytical procedure makes it useful for routine therapeutic monitoring of SRL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076688     DOI: 10.1016/s1570-0232(02)00204-0

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

Authors:  Piero Ruggenenti; Giorgio Gentile; Norberto Perico; Annalisa Perna; Luca Barcella; Matias Trillini; Monica Cortinovis; Claudia Patricia Ferrer Siles; Jorge Arturo Reyes Loaeza; Maria Carolina Aparicio; Giorgio Fasolini; Flavio Gaspari; Davide Martinetti; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Anna Caroli; Kanishka Sharma; Luca Antiga; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-22       Impact factor: 8.237

2.  Wide electrochemical window of screen-printed electrode for determination of rapamycin using ionic liquid/graphene composites.

Authors:  Sudkate Chaiyo; Sakda Jampasa; Natnicha Thongchue; Eda Mehmeti; Weena Siangproh; Orawon Chailapakul; Kurt Kalcher
Journal:  Mikrochim Acta       Date:  2020-03-24       Impact factor: 5.833

3.  Sirolimus therapy to halt the progression of ADPKD.

Authors:  Norberto Perico; Luca Antiga; Anna Caroli; Piero Ruggenenti; Giorgio Fasolini; Mariateresa Cafaro; Patrizia Ondei; Nadia Rubis; Olimpia Diadei; Giulia Gherardi; Silvia Prandini; Andrea Panozo; Rodolfo Flores Bravo; Sergio Carminati; Felipe Rodriguez De Leon; Flavio Gaspari; Monica Cortinovis; Nicola Motterlini; Bogdan Ene-Iordache; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2010-05-13       Impact factor: 10.121

4.  A reversed phase high performance liquid chromatographic method for determination of rapamycin.

Authors:  Hamideh Sobhani; Alireza Shafaati; Nastaran Nafissi-Varcheh; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.